Efficacy of autologous expanded bone marrow derived mesenchymal stem cells (axBM-MSC) in the treatment of patients with chron's disease who have failed to standard therapy: an open-label, randomized controlled clinical trial phase II

Cytotherapy ◽  
2017 ◽  
Vol 19 (5) ◽  
pp. e23 ◽  
Author(s):  
Jhann Arturo ◽  
Carolina Lucena ◽  
Carlos Perez ◽  
Clara Esteban ◽  
Angie L. Vivas Sandoval ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document